Skip to main content

What the FDA labels say about taking them together

Digoxin and propranolol

Propranolol's FDA label (Inderal Xl) of August 27, 2026 names digoxin in its warnings and precautions section; digoxin's label does not name propranolol itself but warns about its class (Beta blockers). The propranolol label: “The concomitant use of beta-adrenergic blockers and non-dihydropyridine calcium channel blockers, digoxin or clonidine increases the risk of significant bradycardia.”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the propranolol FDA label on DailyMed (effective January 15, 2026, Mylan Pharmaceuticals Inc.).

What does the digoxin label say about propranolol?

Digoxin's label does not name propranolol itself; it warns about its class (Beta blockers):

Digoxin label, drug interactions

Beta-adrenergic blockers and calcium channel blockers Additive effects on AV node conduction can result in bradycardia and advanced or complete heart block.

Digoxin label, drug interactions

Supplements Calcium If administered rapidly by intravenous route, can produce serious arrhythmias in digitalized patients. Beta-adrenergic Blockers and Calcium Channel Blockers Additive effects on AV node conduction can result in complete heart block.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the propranolol label say about digoxin?

Inderal Xl label (ANI Pharmaceuticals, Inc., August 27, 2026), warnings and precautions

The concomitant use of beta-adrenergic blockers and non-dihydropyridine calcium channel blockers (e.g., verapamil and diltiazem), digoxin or clonidine increases the risk of significant bradycardia.

Source: FDA drug label (Inderal Xl, NDA021438), ANI Pharmaceuticals, Inc., effective August 27, 2026 (SPL set ac196ff5-9215-402b-bc57-69aa87f8bade), via openFDA

Source: FDA drug label (Propranolol Hydrochloride), Mylan Pharmaceuticals Inc., effective January 15, 2026 (SPL set b94dcec7-7633-4a33-9cea-48161adeaf93), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
42Propranolol generic labelers
DigoxinPropranolol
Labeled forHeart failure, Atrial fibrillationHigh blood pressure, Angina, Atrial fibrillation, Migraine
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$0.0493 per tablet 20 mg tablet
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?